(Q33926147)

30 July 2017

1 reference

title

Vaccination against hepatitis B: current challenges for Asian countries and future directions (English)

1 reference

30 July 2017

1 reference

Safary A

1

1 reference

PubMed ID

10824884

30 July 2017

Beck J

series ordinal

2

1 reference

PubMed ID

10824884

30 July 2017

language of work or name

1 reference

1 April 2000

1 reference

Journal of Gastroenterology and Hepatology

30 July 2017

1 reference

30 July 2017

15

1 reference

30 July 2017

4

1 reference

30 July 2017

396-401

1 reference

Hepatocellular carcinoma. A worldwide problem and the major risk factors

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Treatment and prevention of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Is vaccination against hepatitis B efficient? A review of world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Review: protective efficacy of hepatitis B vaccines in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

International prospects for combined vaccines with emphasis on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Epidemiology of hepatitis B virus infection in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02002.X

10.1046/J.1440-1746.2000.02002.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10824884